$41.995
-0.435[-1.03%]
At close: Apr 25
$42.43
0.4350[1.04%]
After Hours: 4:00PM EDT
MoonLake
(NASDAQ:MLTX)MoonLake Stock (NASDAQ:MLTX), Analyst Ratings, Price Targets, Predictions
MoonLake Immunotherapeutics has a consensus price target of $53.14, established from looking at the 60 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Needham on April 23, 2024, April 11, 2024, and April 9, 2024. With an average price target of $88.67 between HC Wainwright & Co., HC Wainwright & Co., and Needham, there's an implied 111.14% upside for MoonLake Immunotherapeutics from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Needham
Goldman Sachs
Wedbush
Wolfe Research
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for MoonLake
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2024 | MLTX | Buy Now | MoonLake | $41.99 | 138.12% | HC Wainwright & Co. | Raghuram Selvaraju | → $100 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2024 | MLTX | Buy Now | MoonLake | $41.99 | 138.12% | HC Wainwright & Co. | Raghuram Selvaraju | → $100 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | MLTX | Buy Now | MoonLake | $41.99 | 57.16% | Needham | Serge Belanger | → $66 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2024 | MLTX | Buy Now | MoonLake | $41.99 | 47.64% | Goldman Sachs | Richard Law | → $62 | Initiates | → Neutral | Get Alert |
| 03/13/2024 | MLTX | Buy Now | MoonLake | $41.99 | 119.07% | Wedbush | Andreas Argyrides | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2024 | MLTX | Buy Now | MoonLake | $41.99 | 119.07% | Wedbush | Andreas Argyrides | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2024 | MLTX | Buy Now | MoonLake | $41.99 | 138.12% | HC Wainwright & Co. | Raghuram Selvaraju | $75 → $100 | Maintains | Buy | Get Alert |
| 03/11/2024 | MLTX | Buy Now | MoonLake | $41.99 | 57.16% | Needham | Serge Belanger | → $66 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2024 | MLTX | Buy Now | MoonLake | $41.99 | 78.59% | HC Wainwright & Co. | Raghuram Selvaraju | → $75 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | MLTX | Buy Now | MoonLake | $41.99 | 119.07% | Wedbush | Andreas Argyrides | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | MLTX | Buy Now | MoonLake | $41.99 | 57.16% | Needham | Serge Belanger | → $66 | Reiterates | Buy → Buy | Get Alert |
| 02/15/2024 | MLTX | Buy Now | MoonLake | $41.99 | — | Wolfe Research | Andy Chen | — | Initiates | → Outperform | Get Alert |
| 12/18/2023 | MLTX | Buy Now | MoonLake | $41.99 | 64.31% | Stifel | Alex Thompson | $66 → $69 | Maintains | Buy | Get Alert |
| 12/08/2023 | MLTX | Buy Now | MoonLake | $41.99 | 71.45% | Citigroup | Samantha Semenkow | → $72 | Initiates | → Buy | Get Alert |
| 12/01/2023 | MLTX | Buy Now | MoonLake | $41.99 | 119.07% | Wedbush | Andreas Argyrides | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 11/27/2023 | MLTX | Buy Now | MoonLake | $41.99 | 78.59% | HC Wainwright & Co. | Raghuram Selvaraju | → $75 | Reiterates | Buy → Buy | Get Alert |
| 11/16/2023 | MLTX | Buy Now | MoonLake | $41.99 | 119.07% | Wedbush | Andreas Argyrides | $86 → $92 | Maintains | Outperform | Get Alert |
| 11/15/2023 | MLTX | Buy Now | MoonLake | $41.99 | 83.36% | Guggenheim | Yatin Suneja | $70 → $77 | Maintains | Buy | Get Alert |
| 11/08/2023 | MLTX | Buy Now | MoonLake | $41.99 | 85.74% | Cantor Fitzgerald | Prakhar Agrawal | → $78 | Reiterates | Overweight → Overweight | Get Alert |
FAQ
What is the target price for MoonLake (MLTX)?
The latest price target for MoonLake (NASDAQ: MLTX) was reported by HC Wainwright & Co. on April 23, 2024. The analyst firm set a price target for $100.00 expecting MLTX to rise to within 12 months (a possible 138.12% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MoonLake (MLTX)?
The latest analyst rating for MoonLake (NASDAQ: MLTX) was provided by HC Wainwright & Co., and MoonLake reiterated their buy rating.
When was the last upgrade for MoonLake (MLTX)?
There is no last upgrade for MoonLake.
When was the last downgrade for MoonLake (MLTX)?
There is no last downgrade for MoonLake.
When is the next analyst rating going to be posted or updated for MoonLake (MLTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MoonLake, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MoonLake was filed on April 23, 2024 so you should expect the next rating to be made available sometime around April 23, 2025.
Is the Analyst Rating MoonLake (MLTX) correct?
While ratings are subjective and will change, the latest MoonLake (MLTX) rating was a reiterated with a price target of $0.00 to $100.00. The current price MoonLake (MLTX) is trading at is $42.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.